William Kemp

Adjunct Senior Lecturer

MONASH UNIVERSITY

Australia

Research Interests

Explore related searches

Professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

William Kemp is an Adjunct Senior Lecturer at Monash University in Australia. His research areas focus on metabolic dysfunction-associated liver diseases, nutritional influences on health outcomes in older adults, and the application of AI in predicting liver cancer recurrence. Recent publications include studies on the implications of steatotic liver disease, the association of dietary patterns with frailty, and the comparative effectiveness of various treatments for hepatocellular carcinoma.

Articles (19)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Collaborators (12)

purnima bhat

Australian National University

AUSTRALIA

View details

John McNeil

MONASH UNIVERSITY

AUSTRALIA

View details

Avik Majumdar

University of Melbourne

AUSTRALIA

View details

Simone Strasser

Head of Department

AUSTRALIA

View details

John R. Zalcberg

AUSTRALIA

View details

Lisa Bourke

AUSTRALIA

View details

Mark Nelson

Prof

University of Tasmania

AUSTRALIA

View details

Joanne Ryan

MONASH UNIVERSITY

AUSTRALIA

View details

Jessica Fitzpatrick

MONASH UNIVERSITY

AUSTRALIA

View details

Robyn Woods

Associate Professor

MONASH UNIVERSITY

AUSTRALIA

View details

Kumar Visvanathan

Professor, Deputy Chair

University of Melbourne

AUSTRALIA

View details

Chenglong Yu

MONASH UNIVERSITY

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

William Kemp

Research Interests

Explore related searches

Contact this professor

About

Articles (19)

Genetic Variants, Metabolic Dysfunction-Associated Fatty Liver Disease, and Major Health Outcomes in Older Adults

Steatotic Liver Disease in Older Adults: Clinical Implications and Unmet Needs

Associations Between MASLD, Ultra-Processed Food and a Mediterranean Dietary Pattern in Older Adults

Validation of serum non‐invasive tests of liver fibrosis as prognostic markers of clinical outcomes in people with fatty liver disease in Australia

Mediterranean Diet and Ultra-Processed Food Intake in Older Australian Adults—Associations with Frailty and Cardiometabolic Conditions

AI‐powered prediction of HCC recurrence after surgical resection: Personalised intervention opportunities using patient‐specific risk factors

Different Patterns of Care and Survival Outcomes in Transplant-Centre Managed Patients with Early-Stage HCC: Real-World Data from an Australian Multi-Centre Cohort Study

Validation of a novel point-of-care test for alanine aminotransferase measurement: A pilot cohort study.

Metabolic dysfunction‐associated steatotic liver disease in older adults is associated with frailty and social disadvantage

Non‐alcoholic fatty liver disease prevalence in Australia has risen over 15 years in conjunction with increased prevalence of obesity and reduction in healthy lifestyle

The Effect of Aspirin Use on Incident Hepatocellular Carcinoma—An Updated Systematic Review and Meta-Analysis

Reply to Abenavoli et al. Comment on “Clayton-Chubb et al. Understanding NAFLD: From Case Identification to Interventions, Outcomes, and Future Perspectives. Nutrients 2023, 15, 687”

Current Therapeutics in Primary Sclerosing Cholangitis

Understanding NAFLD: From Case Identification to Interventions, Outcomes, and Future Perspectives

Improved survival of cirrhotic patients with infections in Australian and New Zealand ICUs between 2005 and 2017

Liver stiffness (Fibroscan®) is a predictor of all‐cause mortality in people with non‐alcoholic fatty liver disease

Improved Survival Outcomes with Surgical Resection Compared to Ablative Therapy in Early-Stage HCC: A Large, Real-World, Propensity-Matched, Multi-Centre, Australian Cohort Study

A multi‐site, nurse‐coordinated hepatitis C model of care in primary care and community services in Melbourne, Australia

Collaborators (12)

purnima bhat

John McNeil

Avik Majumdar

Simone Strasser

John R. Zalcberg

Lisa Bourke

Mark Nelson

Joanne Ryan

Jessica Fitzpatrick

Robyn Woods

Kumar Visvanathan

Chenglong Yu

Make your next move.